Core Laboratories N.V. Statistics
Share Statistics
Core Laboratories N.V. has 46.95M shares outstanding. The number of shares has increased by 0.53% in one year.
| Shares Outstanding | 46.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 46.53M |
| Failed to Deliver (FTD) Shares | 6 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 6.95M, so 14.81% of the outstanding shares have been sold short.
| Short Interest | 6.95M |
| Short % of Shares Out | 14.81% |
| Short % of Float | 14.94% |
| Short Ratio (days to cover) | 21.39 |
Valuation Ratios
The PE ratio is 22.48 and the forward PE ratio is 21.38. Core Laboratories N.V.'s PEG ratio is 0.35.
| PE Ratio | 22.48 |
| Forward PE | 21.38 |
| PS Ratio | 1.62 |
| Forward PS | 1.6 |
| PB Ratio | 3.67 |
| P/FCF Ratio | 58.02 |
| PEG Ratio | 0.35 |
Enterprise Valuation
Core Laboratories N.V. has an Enterprise Value (EV) of 1.02B.
| EV / Earnings | 27.94 |
| EV / Sales | 2.01 |
| EV / EBITDA | 14.55 |
| EV / EBIT | 18.75 |
| EV / FCF | 72.11 |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.73.
| Current Ratio | 2.53 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.73 |
| Total Debt / Capitalization | 42.05 |
| Cash Flow / Debt | 0.15 |
| Interest Coverage | 4.07 |
Financial Efficiency
Return on equity (ROE) is 0.16% and return on capital (ROIC) is 11.03%.
| Return on Equity (ROE) | 0.16% |
| Return on Assets (ROA) | 0.06% |
| Return on Capital (ROIC) | 11.03% |
| Revenue Per Employee | 145.65K |
| Profits Per Employee | 10.48K |
| Employee Count | 3.50K |
| Asset Turnover | 0.87 |
| Inventory Turnover | 5.8 |
Taxes
| Income Tax | 4.18M |
| Effective Tax Rate | 0.1 |
Stock Price Statistics
The stock price has increased by 6.83% in the last 52 weeks. The beta is 2.36, so Core Laboratories N.V.'s price volatility has been higher than the market average.
| Beta | 2.36 |
| 52-Week Price Change | 6.83% |
| 50-Day Moving Average | 19.69 |
| 200-Day Moving Average | 18.81 |
| Relative Strength Index (RSI) | 47.45 |
| Average Volume (20 Days) | 304.85K |
Income Statement
In the last 12 months, Core Laboratories N.V. had revenue of $509.79M and earned $36.67M in profits. Earnings per share was $0.79.
| Revenue | 509.79M |
| Gross Profit | 94.05M |
| Operating Income | 54.64M |
| Net Income | 36.67M |
| EBITDA | 70.42M |
| EBIT | 54.64M |
| Earnings Per Share (EPS) | 0.79 |
Balance Sheet
The company has $15.12M in cash and $215.38M in debt, giving a net cash position of -$200.26M.
| Cash & Cash Equivalents | 15.12M |
| Total Debt | 215.38M |
| Net Cash | -200.26M |
| Retained Earnings | 120.76M |
| Total Assets | 600.47M |
| Working Capital | 140.29M |
Cash Flow
In the last 12 months, operating cash flow was $24.79M and capital expenditures -$10.58M, giving a free cash flow of $14.21M.
| Operating Cash Flow | 24.79M |
| Capital Expenditures | -10.58M |
| Free Cash Flow | 14.21M |
| FCF Per Share | 0.3 |
Margins
Gross margin is 18.45%, with operating and profit margins of 10.72% and 7.19%.
| Gross Margin | 18.45% |
| Operating Margin | 10.72% |
| Pretax Margin | 8.08% |
| Profit Margin | 7.19% |
| EBITDA Margin | 13.81% |
| EBIT Margin | 10.72% |
| FCF Margin | 2.79% |
Dividends & Yields
CLB pays an annual dividend of $0.04, which amounts to a dividend yield of 0.2%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.2% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 7.41% |
| Earnings Yield | 4.07% |
| FCF Yield | 1.56% |
Analyst Forecast
The average price target for CLB is $16, which is -17.5% lower than the current price. The consensus rating is "Sell".
| Price Target | $16 |
| Price Target Difference | -17.5% |
| Analyst Consensus | Sell |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 3.43 |
| Piotroski F-Score | 6 |